head 3

Virgin Atlantic is set to trial vaccine passports

DUBLIN: The airline Virgin Atlantic is ready to trail the vaccine passports. The first vaccine passports will be tested on passengers on flights to Barbados from April 16. The Travel Pass application is used to verify compliance with Caribbean island entry requirements. Corona virus vaccine records are integrated into updated versions of this app. It was developed by the Airline Trade Body International Air Transport Association.

Virgin Atlantic has announced that it will seek permission from the UK government to extend the trial to travellers arriving on flights from Barbados to London Heathrow. Many airlines, including British Airways, Singapore Airlines, Emirates, Qantas, and Qatar Airways, use the app.

From next week, travelers flying to the US on the Virgin Atlantic will be able to upload their test documents to a website run by the US firm TrustAssure. It will be tested using automated artificial intelligence (AI) technology within two minutes. It will be tested using automated artificial intelligence (AI) technology within two minutes. Once the check-in is complete, passengers will receive a QR code that enables them to pass through the airport check-in process, allowing them to travel.

Corneel Koster, Virgin Atlantic’s Chief Customer and Operating Officer, said the plan is to promote air travel. He added that rapid testing in conjunction with digital health integration would make a big difference.

Due to the COVID-19 lockdown in UK, unauthorized foreign travel has been banned. Prime Minister Boris Johnson has confirmed that the restrictions will be lifted on April 5. The UK Government’s Global Travel Task Force will make recommendations to the British Prime Minister on April 12 on how and when to resume overseas holidays. There are indications that foreign travel may be allowed as part of the easing of restrictions from May 17.

Kindly click the link below to join WhatsApp group chat to get important news and breaking news from Irish Samachar


Comments are closed.